By creating a free Inderes account, you get access to Inderes analysis, you can order the popular morning review and follow companies and discussions that interest you.
Already have an account?
Follow this company like 10798 other investors.
Analyytikko
Redeye will not make any immediate adjustments following the lowered guidance for 2022 from Remedy. Our research update published in April expected relatively slow revenue growth and a significantly lower EBIT compared to 2021.
Fem intressanta bolag på Helsingforsbörsen enligt Isa Hudd och Verneri Pulkkinen.Videoinnehåll:00:00 Introduktion00:25 Sampo: förutsägbar business till låg risk00:50 Remedy Entertainment: spelutvecklare med flera intressanta spel i loopen01:58 Talenom: defensivt tillväxtbolag som expanderar internationellt02:41 Revenio Group: världsledande hälsoteknologi med inriktning på ögonsjukdomar03:36 Neste: världens största producent av förnybar diesel och förnybart jetbränsleLäs mer om Sampo här:
Redeye has done some adjustments after the Q1 result. Remedy has five ongoing projects which means one of the biggest challenges going forward is to find the best possible personnel to recruit.
Redeye comments on Remedy’s Q1 business review. Revenue was EUR 1.3 million above our estimate, EUR 12.7 million versus EUR 11.4 million. The cost base was roughly in line, which resulted in an EBIT somewhat above our estimate.
Redeye updates its financial projections in Remedy Entertainment. The gaming studio has secured two significant agreements with two of the biggest players in the industry, namely Tencent and Take-Two Interactive.
Redeye comment on Remedy’s full-year report. Remedy posted an EBIT result in line with our estimated and somewhat higher revenue than expected.
Redeye comments on the favorable Tencent agreement and updates its estimates for 2022. A few days before New Year’s Eve Remedy announced the awaited partnership agreement for its upcoming co-operative multiplayer game codenamed Vanguard.
During the night Swedish Time (around 2:00 AM), The Game Awards will be held. This will be a big event for Nordic Gaming. Microsoft will most likely reveal the launch date for Crossfire X.
Redeye comment on the Q3 business review. Remedy reported an undramatic quarter that had a dramatic impact on the stock price, currently down almost 8%. The outlook for the year is unchanged and the business progressed as planned.
Redeye comments on Remedy’s stable H1-report. Revenue amounted to EUR 17.5 million which is above our estimated EUR 15.6 million.
